Home » Authors » James Etheridge

Articles by James Etheridge

French Biotech Growing But Still Lagging Behind

Oct. 10, 2007

By James Etheridge

DBV And Numico Extend Their Allergy Pact Globally

Oct. 3, 2007

By James Etheridge

DBV And Numico Extend Their Allergy Pact Globally

Oct. 3, 2007

By James Etheridge

Polyplus-transfection Enters RNAi Deal With Alnylam Pharma

Sep. 26, 2007

By James Etheridge

Polyplus-transfection Enters RNAi Deal With Alnylam Pharma

Sep. 26, 2007

By James Etheridge

Mutabilis, Oroxcell Collaborate On Preclinical Antibiotic Agent

Sep. 19, 2007

By James Etheridge

Mutabilis, Oroxcell Collaborate On Preclinical Antibiotic Agent

Sep. 19, 2007

By James Etheridge

BioAlliance Launches Loramyc; Pleased With Pricing Directive

Sep. 12, 2007

By James Etheridge

BioAlliance Launches Loramyc; Pleased With Pricing Directive

Sep. 12, 2007

By James Etheridge

Trophos Raises €8.5M To Move Compound Into Phase II Trials

Sep. 5, 2007

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...